JRCM
DNA.WS

Jones Road Capital Management’s Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share DNA.WS Stock Holding History

Jones Road Capital Management’s Portfolio DNA.WS Stock Details DNA.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50,000
Closed -$16.7K – 44
2024
Q2 		$16.7K Hold
50,000
– – 0.01% 34
2024
Q1 		$58K Hold
50,000
– – 0.04% 32
2023
Q4 		$84.5K Hold
50,000
– – 0.02% 39
2023
Q3 		$90.5K Hold
50,000
– – 0.08% 34
2023
Q2 		$93K Hold
50,000
– – 0.07% 35
2023
Q1 		$66.5K Hold
50,000
– – 0.05% 37
2022
Q4 		$84.5K Hold
50,000
– – 0.08% 35
2022
Q3 		$156K Hold
50,000
– – 0.11% 45
2022
Q2 		$119K Hold
50,000
– – 0.06% 49
2022
Q1 		$202K Hold
50,000
– – 0.09% 54
2021
Q4 		$416K Hold
50,000
– – 0.09% 60
2021
Q3 		$580K Buy
+50,000
New +$178K 0.19% 53

Other funds holding DNA.WS

AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
SBLIC
Security Benefit Life Insurance Company Topeka, Kansas $182M AUM 31.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Jones Road Capital Management's DNA.WS Position: Q3 2024 in Review

Jones Road Capital Management sold out of Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share (DNA.WS) in Q3 2024, closing a stake of 50,000 shares — an estimated $16.7K sold.

Jones Road Capital Management first reported a position in DNA.WS in Q3 2021 and held it in 12 quarters. The position peaked at $580K in Q3 2021. 5 funds tracked by Wall St. Rank hold DNA.WS as of Q3 2024.

  • Jones Road Capital Management reported no remaining Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position as of Q3 2024 after selling out during the quarter.
  • Jones Road Capital Management sold 50,000 Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share shares in Q3 2024, an estimated $16.7K.
  • Jones Road Capital Management first reported a position in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in Q3 2021 and held it in 12 quarters.
  • Jones Road Capital Management's Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share position peaked at $580K in Q3 2021.
  • 5 funds tracked by Wall St. Rank held Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share as of Q3 2024.

Based on Jones Road Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.